YouthBio Therapeutics
Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors
Pioneering tissue-specific gene therapies to rejuvenate tissues, improve organ function and, ultimately, delay aging.
At YouthBio, our mission is to harness the power of cellular reprogramming to restore a more youthful gene expression profile in targeted cells, leading to positive therapeutic effects in corresponding organs. Our ultimate goal is achieving systemic rejuvenation by targeting multiple key organ systems via tailored therapies. To get there, we are first starting with single-organ therapies aimed at existing diseases.
Discover the incredible potential of partial reprogramming to revolutionize the way we combat and prevent age-related diseases, and ultimately delay or possibly even reverse aging.
YouthBio Therapeutics Executive Team
- Yuri Deigin - Co-founder and Director
- Viet Ly - Co-founder and CFO
- João Pedro de Magalhães - Chief Scientific Officer
- Alejandro Ocampo - Lead Research Collaborator
- Stephanie Chang - CFO
Visit website: https://youthbiotx.com/
Details last updated 02-Apr-2022
Mentioned in this Resource
João Pedro de Magalhães
Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker
Viet Ly
Co-founder and CFO at YouthBio Therapeutics and General Partner/ Fund Manager at Inception Capital
YouthBio Therapeutics News
Unveiling the future of age reversal: meet Yuri Deigin, founder of YouthBio Therapeutics
Longevity Technology - 08-Mar-2023
Tissue-specific gene therapies & rejuvenating factors to extend lifespan and combat age-related diseases
Read more...Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trials
Read more...Lifespan.io interviews João Pedro de Magalhães about theories of, and curing, ageing
Lifespan.io (LEAF) - 13-May-2022
The one thing I hope he's wrong about is that it won't happen in his lifetime - we just need some exponential oomph!
Read more...YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO
CISION PR Newswire - 14-Apr-2022
Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line
Read more...
